Similar articles for PMID: 22988057

Year	Number of Results
2004	1
2007	1
2008	2
2009	2
2010	5
2011	10
2012	13
2013	15
2014	11
2015	14
2016	11
2017	13
2018	10
2019	7
2020	8
2021	5
2022	8
2024	0

1

Immuno-PET of tissue factor in pancreatic cancer.

Hong H, Zhang Y, Nayak TR, Engle JW, Wong HC, Liu B, Barnhart TE, Cai W. Hong H, et al. J Nucl Med. 2012 Nov;53(11):1748-54. doi: 10.2967/jnumed.112.105460. Epub 2012 Sep 17. J Nucl Med. 2012. PMID: 22988057 Free PMC article.

2

PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site-Inhibited Factor VII.

Nielsen CH, Jeppesen TE, Kristensen LK, Jensen MM, El Ali HH, Madsen J, Wiinberg B, Petersen LC, Kjaer A. Nielsen CH, et al. J Nucl Med. 2016 Jul;57(7):1112-9. doi: 10.2967/jnumed.115.170266. Epub 2016 Mar 24. J Nucl Med. 2016. PMID: 27013699 Free article.

3

ImmunoPET imaging of tissue factor expression in pancreatic cancer with ⁸⁹Zr-Df-ALT-836.

Hernandez R, England CG, Yang Y, Valdovinos HF, Liu B, Wong HC, Barnhart TE, Cai W. Hernandez R, et al. J Control Release. 2017 Oct 28;264:160-168. doi: 10.1016/j.jconrel.2017.08.029. Epub 2017 Aug 24. J Control Release. 2017. PMID: 28843831 Free PMC article.

4

ImmunoPET of tissue factor expression in triple-negative breast cancer with a radiolabeled antibody Fab fragment.

Shi S, Hong H, Orbay H, Graves SA, Yang Y, Ohman JD, Liu B, Nickles RJ, Wong HC, Cai W. Shi S, et al. Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1295-303. doi: 10.1007/s00259-015-3038-1. Epub 2015 Mar 24. Eur J Nucl Med Mol Imaging. 2015. PMID: 25801992 Free PMC article.

5

ImmunoPET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer with a Dual-Labeled Bispecific Antibody Fragment.

Luo H, England CG, Goel S, Graves SA, Ai F, Liu B, Theuer CP, Wong HC, Nickles RJ, Cai W. Luo H, et al. Mol Pharm. 2017 May 1;14(5):1646-1655. doi: 10.1021/acs.molpharmaceut.6b01123. Epub 2017 Mar 24. Mol Pharm. 2017. PMID: 28292180 Free PMC article.

6

MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.

Boyle AJ, Cao PJ, Hedley DW, Sidhu SS, Winnik MA, Reilly RM. Boyle AJ, et al. Nucl Med Biol. 2015 Feb;42(2):71-7. doi: 10.1016/j.nucmedbio.2014.10.009. Epub 2014 Oct 22. Nucl Med Biol. 2015. PMID: 25456837

7

PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab.

Luo H, England CG, Graves SA, Sun H, Liu G, Nickles RJ, Cai W. Luo H, et al. J Nucl Med. 2016 Feb;57(2):285-90. doi: 10.2967/jnumed.115.166462. Epub 2015 Nov 5. J Nucl Med. 2016. PMID: 26541778 Free PMC article.

8

PET of c-Met in Cancer with ⁶⁴Cu-Labeled Hepatocyte Growth Factor.

Luo H, Hong H, Slater MR, Graves SA, Shi S, Yang Y, Nickles RJ, Fan F, Cai W. Luo H, et al. J Nucl Med. 2015 May;56(5):758-63. doi: 10.2967/jnumed.115.154690. Epub 2015 Apr 3. J Nucl Med. 2015. PMID: 25840981 Free PMC article.

9

Quantitative PET Imaging of Tissue Factor Expression Using 18F-Labeled Active Site-Inhibited Factor VII.

Nielsen CH, Erlandsson M, Jeppesen TE, Jensen MM, Kristensen LK, Madsen J, Petersen LC, Kjaer A. Nielsen CH, et al. J Nucl Med. 2016 Jan;57(1):89-95. doi: 10.2967/jnumed.115.154849. Epub 2015 Sep 17. J Nucl Med. 2016. PMID: 26383146 Free article.

10

Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice.

Jeong JM, Hong MK, Chang YS, Lee YS, Kim YJ, Cheon GJ, Lee DS, Chung JK, Lee MC. Jeong JM, et al. J Nucl Med. 2008 May;49(5):830-6. doi: 10.2967/jnumed.107.047423. Epub 2008 Apr 15. J Nucl Med. 2008. PMID: 18413379 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

115 results

Results by year